BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11836319)

  • 1. Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro(12)Ala polymorphism in the PPARgamma gene.
    Hara M; Alcoser SY; Qaadir A; Beiswenger KK; Cox NJ; Ehrmann DA
    J Clin Endocrinol Metab; 2002 Feb; 87(2):772-5. PubMed ID: 11836319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the (AU)AT-rich element polymorphism in PPP1R3 with hormonal and metabolic features of polycystic ovary syndrome.
    Alcoser SY; Hara M; Bell GI; Ehrmann DA
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2973-6. PubMed ID: 15181086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
    Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
    Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome.
    Hahn S; Fingerhut A; Khomtsiv U; Khomtsiv L; Tan S; Quadbeck B; Herrmann BL; Knebel B; Müller-Wieland D; Mann K; Janssen OE
    Clin Endocrinol (Oxf); 2005 May; 62(5):573-9. PubMed ID: 15853827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations.
    Kauffman RP; Baker VM; Dimarino P; Gimpel T; Castracane VD
    Am J Obstet Gynecol; 2002 Nov; 187(5):1362-9. PubMed ID: 12439532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome.
    Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Cakir N; Arslan M
    Gynecol Endocrinol; 2006 Jun; 22(6):336-42. PubMed ID: 16785159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome.
    Ehrmann DA; Schwarz PE; Hara M; Tang X; Horikawa Y; Imperial J; Bell GI; Cox NJ
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1669-73. PubMed ID: 11932299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in the insulin receptor substrate-1 (IRS-1) gene and the insulin receptor substrate-2 (IRS-2) gene influence glucose homeostasis and body mass index in women with polycystic ovary syndrome and non-hyperandrogenic controls.
    Villuendas G; Botella-Carretero JI; Roldán B; Sancho J; Escobar-Morreale HF; San Millán JL
    Hum Reprod; 2005 Nov; 20(11):3184-91. PubMed ID: 16037106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome.
    Ehrmann DA; Tang X; Yoshiuchi I; Cox NJ; Bell GI
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4297-300. PubMed ID: 12213887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?
    Wijeyaratne CN; Balen AH; Barth JH; Belchetz PE
    Clin Endocrinol (Oxf); 2002 Sep; 57(3):343-50. PubMed ID: 12201826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism in the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome.
    Korhonen S; Heinonen S; Hiltunen M; Helisalmi S; Hippeläinen M; Koivunen R; Tapanainen JS; Laakso M
    Hum Reprod; 2003 Mar; 18(3):540-3. PubMed ID: 12615821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher high-density lipoprotein cholesterol in African-American women with polycystic ovary syndrome compared with Caucasian counterparts.
    Koval KW; Setji TL; Reyes E; Brown AJ
    J Clin Endocrinol Metab; 2010 Sep; 95(9):E49-53. PubMed ID: 20534766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of IL-18 genotype with impaired glucose regulation in Korean women with polycystic ovary syndrome.
    Kim JW; Lee MH; Park JE; Yoon TK; Lee WS; Shim SH
    Eur J Obstet Gynecol Reprod Biol; 2012 Mar; 161(1):51-5. PubMed ID: 22226490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro12Ala of the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower serum insulin levels in nonobese African Americans: the Atherosclerosis Risk in Communities Study.
    Kao WH; Coresh J; Shuldiner AR; Boerwinkle E; Bray MS; Brancati FL;
    Diabetes; 2003 Jun; 52(6):1568-72. PubMed ID: 12765972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome.
    Stovall DW; Bailey AP; Pastore LM
    J Womens Health (Larchmt); 2011 Jan; 20(1):37-43. PubMed ID: 21194310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.
    Arslanian SA; Lewy V; Danadian K; Saad R
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1555-9. PubMed ID: 11932281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism of glycogen synthetase gene in polycystic ovary syndrome.
    Rajkhowa M; Talbot JA; Jones PW; Clayton RN
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):85-90. PubMed ID: 8706299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exon 6 and 2 peroxisome proliferator-activated receptor-gamma polymorphisms in polycystic ovary syndrome.
    Orio F; Matarese G; Di Biase S; Palomba S; Labella D; Sanna V; Savastano S; Zullo F; Colao A; Lombardi G
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5887-92. PubMed ID: 14671186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of MEP1A gene variants with insulin metabolism in central European women with polycystic ovary syndrome.
    Lam UD; Lerchbaum E; Schweighofer N; Trummer O; Eberhard K; Genser B; Pieber TR; Obermayer-Pietsch B
    Gene; 2014 Mar; 537(2):245-52. PubMed ID: 24388959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.